Comparative Study of the Magnetically Guided Capsule Endoscopy Versus High Definition Gastroscopy

NCT01555840 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 189

Last updated 2019-06-18

No results posted yet for this study

Summary

A capsule steered by magnetic field force developed by Siemens and Olympus has recently been evaluated in a pilot series in man with encouraging results (Rey JF, Ogata H, Hosoe N, Ohtsuka K, Ogata N, Ikeda K, Aihara H, Pangtay I, Hibi T, Kudo S, Tajiri H. Feasibility of stomach exploration with a guided capsule endoscope. Endoscopy. 2010;42:541-5. Epub 2010 Jun 30.18). This blinded prospective study investigates the accuracy of the magnetically guided capsule (MGCE) compared to gastroscopy in patients with focal lesions and / or gastric symptoms and indication for upper GI Endoscopy.

Conditions

  • Gastric Focal Lesion

Interventions

DEVICE

Magnetically Guided Capsule (MGCE)

"a) MGCE capsule The MGCE capsule is custom-made for observation of the stomach. It is 31 mm in length and 11 mm in diameter and equipped with two image sensors. It contains a permanent magnet to enable magnetic guidance in the stomach by magnetic field." "b) Guidance system The magnet guidance system is custom-made to guide the MGCE capsule inside the stomach. It has a footprint of 1m× 2m and generates a very low level magnetic fields." c) Conventional gastroscope

Sponsors & Collaborators

  • Institute Arnault Tzanck, France

    collaborator OTHER
  • Centre Hospitalier Universitaire de Nice

    collaborator OTHER
  • Keio University

    collaborator OTHER
  • Showa University Northern Yokohama Hospital, Japan

    collaborator UNKNOWN
  • The Jikei University School of Medicine, Japan

    collaborator UNKNOWN
  • Olympus Corporation

    collaborator INDUSTRY
  • Siemens AG

    collaborator INDUSTRY
  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • J F Rey, MD · Institut Arnault Tzanck, St. Laurent du Var, France

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-05-31
Completion
2012-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01555840 on ClinicalTrials.gov